Anti-CTLA-4 therapy-associated granuloma annulare in chronic myelomonocytic leukemia
Sign Up to like & getrecommendations! Published in 2020 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2020.1818165
Abstract: Abstract Immune checkpoint inhibitor (ICI) therapies activate the immune system to unmask cancer cells that the body might otherwise not detect. These cancer therapies alter the immune system at different “checkpoint” proteins such as PD-1,… read more here.
Keywords: anti ctla; ctla therapy; chronic myelomonocytic; therapy ... See more keywords